Global Pneumonia Therapeutics Market by Drug Class, Pneumonia Type, Age Group, Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Pneumonia Therapeutics Market by Drug Class, Pneumonia Type, Age Group, Distribution Channel - Forecast 2024-2030

Report
188 Pages
March 2024
Region: Global
360iResearch™
ID: 5888889

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The Pneumonia Therapeutics Market size was estimated at USD 15.34 billion in 2023, USD 16.64 billion in 2024, and is expected to grow at a CAGR of 8.93% to reach USD 27.93 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pneumonia Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pneumonia Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pneumonia Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Allergan plc, AstraZeneca PLC, Aurobindo Pharma Limited, Bayer AG, Biobrick Pharma, Cipla Limited, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Lincoln Pharmaceuticals Ltd., Lupin Pharmaceuticals, Inc., Mankind Pharma Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Seqirus UK Limited by CSL Limited, Serum Institute of India, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Wellona Pharma, and Zydus Healthcare Limited.

Market Segmentation & Coverage

This research report categorizes the Pneumonia Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Class
- Antibacterial Drugs
- Antifungal Drugs
- Antiviral Drugs
Pneumonia Type
- Community-acquired pneumonia (CAP)
- Hospital-acquired pneumonia (HAP)
- Ventilator-associated pneumonia (VAP)
Age Group
- Adult
- Geriatric
- Pediatrics
Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Pneumonia Therapeutics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pneumonia Therapeutics Market?
What are the technology trends and regulatory frameworks in the Pneumonia Therapeutics Market?
What is the market share of the leading vendors in the Pneumonia Therapeutics Market?
Which modes and strategic moves are suitable for entering the Pneumonia Therapeutics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Pneumonia Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of pneumonia and the need for efficient treatment
5.1.1.2. Significant investments in research & development of pneumonia-therapeutics
5.1.1.3. Increasing availability of generic and cost-effective pneumonia drugs
5.1.2. Restraints
5.1.2.1. Prolonged treatment duration for pneumonia
5.1.3. Opportunities
5.1.3.1. Emerging technologies to improve diagnosis and treatment of pneumonia
5.1.3.2. Growing emphasis on personalized medicine for the production of efficient drugs
5.1.4. Challenges
5.1.4.1. Potential side effects associated with certain pneumonia therapies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Pneumonia Therapeutics Market, by Drug Class

6.1. Introduction
6.2. Antibacterial Drugs
6.3. Antifungal Drugs
6.4. Antiviral Drugs

7. Pneumonia Therapeutics Market, by Pneumonia Type

7.1. Introduction
7.2. Community-acquired pneumonia (CAP)
7.3. Hospital-acquired pneumonia (HAP)
7.4. Ventilator-associated pneumonia (VAP)

8. Pneumonia Therapeutics Market, by Age Group

8.1. Introduction
8.2. Adult
8.3. Geriatric
8.4. Pediatrics

9. Pneumonia Therapeutics Market, by Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies

10. Americas Pneumonia Therapeutics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pneumonia Therapeutics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Pneumonia Therapeutics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Allergan plc
14.1.3. AstraZeneca PLC
14.1.4. Aurobindo Pharma Limited
14.1.5. Bayer AG
14.1.6. Biobrick Pharma
14.1.7. Cipla Limited
14.1.8. Dr. Reddy's Laboratories Ltd.
14.1.9. Eli Lilly and Company
14.1.10. F. Hoffmann-La Roche Ltd.
14.1.11. GlaxoSmithKline PLC
14.1.12. Hikma Pharmaceuticals PLC
14.1.13. Lincoln Pharmaceuticals Ltd.
14.1.14. Lupin Pharmaceuticals, Inc.
14.1.15. Mankind Pharma Ltd.
14.1.16. Merck & Co., Inc.
14.1.17. Novartis AG
14.1.18. Pfizer Inc.
14.1.19. Sanofi S.A.
14.1.20. Seqirus UK Limited by CSL Limited
14.1.21. Serum Institute of India
14.1.22. Sun Pharmaceutical Industries Ltd.
14.1.23. Teva Pharmaceutical Industries Ltd.
14.1.24. Viatris Inc.
14.1.25. Wellona Pharma
14.1.26. Zydus Healthcare Limited
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. PNEUMONIA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. PNEUMONIA THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. PNEUMONIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PNEUMONIA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PNEUMONIA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PNEUMONIA THERAPEUTICS MARKET DYNAMICS
FIGURE 7. PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 8. PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2023 VS 2030 (%)
FIGURE 10. PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 12. PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PNEUMONIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. PNEUMONIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PNEUMONIA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PNEUMONIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PNEUMONIA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 6. PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIBACTERIAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIFUNGAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PNEUMONIA THERAPEUTICS MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 10. PNEUMONIA THERAPEUTICS MARKET SIZE, BY COMMUNITY-ACQUIRED PNEUMONIA (CAP), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PNEUMONIA THERAPEUTICS MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA (HAP), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PNEUMONIA THERAPEUTICS MARKET SIZE, BY VENTILATOR-ASSOCIATED PNEUMONIA (VAP), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 14. PNEUMONIA THERAPEUTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PNEUMONIA THERAPEUTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PNEUMONIA THERAPEUTICS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. PNEUMONIA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PNEUMONIA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PNEUMONIA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. CANADA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 35. CANADA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. CANADA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. MEXICO PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 39. MEXICO PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 41. MEXICO PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CHINA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 57. CHINA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 58. CHINA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. CHINA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. INDIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 61. INDIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 63. INDIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. JAPAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 69. JAPAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 71. JAPAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. THAILAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 93. THAILAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 95. THAILAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. DENMARK PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 108. DENMARK PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EGYPT PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 110. EGYPT PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. EGYPT PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FINLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 114. FINLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. FINLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 120. FRANCE PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. GERMANY PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 130. ITALY PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 132. ITALY PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NORWAY PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 142. NORWAY PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 144. NORWAY PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. POLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 146. POLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 147. POLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. POLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. QATAR PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 150. QATAR PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 151. QATAR PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. QATAR PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. SPAIN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 178. TURKEY PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. TURKEY PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PNEUMONIA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM PNEUMONIA THERAPEUTICS MARKET SIZE, BY PNEUMONIA TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PNEUMONIA THERAPEUTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM PNEUMONIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. PNEUMONIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. PNEUMONIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. PNEUMONIA THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Allergan plc
AstraZeneca PLC
Aurobindo Pharma Limited
Bayer AG
Biobrick Pharma
Cipla Limited
Dr. Reddy's Laboratories Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
Lincoln Pharmaceuticals Ltd.
Lupin Pharmaceuticals, Inc.
Mankind Pharma Ltd.
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sanofi S.A.
Seqirus UK Limited by CSL Limited
Serum Institute of India
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Wellona Pharma
Zydus Healthcare Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 16.64 Billion
Forecasted Market Value ( USD ) by 2030	$ 27.93 Billion
Compound Annual Growth Rate	8.9%
Regions Covered	Global
No. of Companies Mentioned	26

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Pneumonia Therapeutics - Global Strategic Business Report

Pneumonia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Ventilator Associated Pneumonia Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Bacterial Pneumonia Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Global Hospital Infection Therapeutics Market by Drug Type (Antibacterial Drugs, Antifungal Drugs, Antiviral Drugs), Infections (Bloodstream Infections, Gastrointestinal Disorders, Hospital-Acquired Pneumonia) - Forecast 2024-2030

About the Pneumonia Drug Market